Post-earnings recap
Reported
Mon, Nov 4, 2024
EPS actual
$0.08
EPS est.
$-0.06
EPS surprise
+233.33%
1-day move
+1.48%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Castle Biosciences reported a positive surprise in EPS, which led to a 1.48% increase in stock price. However, there was no revenue reported, and no guidance was provided. Investors may view the EPS beat as a positive sign, but the lack of revenue information leaves some uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.08 | N/A | +233.33% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.